J&J resumes roll-out of COVID-19 vaccine in EU
21st April 2021 Uncategorised 0EMA’s safety committee has confirmed the overall benefit-risk profile of the jab More: J&J resumes roll-out of COVID-19 vaccine in EU Source: News
read moreEMA’s safety committee has confirmed the overall benefit-risk profile of the jab More: J&J resumes roll-out of COVID-19 vaccine in EU Source: News
read moreFirst self-administered, targeted B-cell therapy licensed for adults with relapsing forms of MS More: Novartis’ MS therapy Kesimpta wins NICE backing Source: News
read moreAntivirals Taskforce established in a bid to identify promising at-home antiviral medicines More: UK government launches search for at-home COVID-19 treatments Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals